Alkermes
evolution of alkermes strategy focus management new molecules leveraging scientific capabilities new strategy focus two areas of scientific and oncology programs with validated biology rationale leverage established small molecule and protein design capabilities management utilize an integrated approach to target evaluation design development programs to provide key data early and allocate resources based on data scientific excellence molecular design medicinal chemistry and protein engineering applied to develop novel molecules to address unmet needs in and oncology by | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
6 of 144
Related slides by other companies
Allwyn
Investor Conference
January 2024
key pillars of our organic growth strategy digital lottery retail lottery cross sell | Allwyn
Cytek
Investor Day
June 2022
commercial and reagent strategy a | Cytek
Lanvin
Investor Presentation
May 2023
key strategies and achievements | Lanvin
Eutelsat
Investor Presentation
November 2023
approach four major areas of focus | Eutelsat
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io